Cargando…
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
Renal cell carcinoma (RCC) is one of the most chemo- and radio-resistant malignancies, with poor associated patient survival if the disease metastasizes. With recent advances in immunotherapy, particularly with PD-1/PD-L1 blockade, outcomes are improving, but a substantial subset of patients does no...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694809/ https://www.ncbi.nlm.nih.gov/pubmed/26317902 |
_version_ | 1782407527353286656 |
---|---|
author | Baine, Marina K. Turcu, Gabriela Zito, Christopher R. Adeniran, Adebowale J. Camp, Robert L. Chen, Lieping Kluger, Harriet M. Jilaveanu, Lucia B. |
author_facet | Baine, Marina K. Turcu, Gabriela Zito, Christopher R. Adeniran, Adebowale J. Camp, Robert L. Chen, Lieping Kluger, Harriet M. Jilaveanu, Lucia B. |
author_sort | Baine, Marina K. |
collection | PubMed |
description | Renal cell carcinoma (RCC) is one of the most chemo- and radio-resistant malignancies, with poor associated patient survival if the disease metastasizes. With recent advances in immunotherapy, particularly with PD-1/PD-L1 blockade, outcomes are improving, but a substantial subset of patients does not respond to the new agents. Identifying such patients and improving the therapeutic ratio has been a challenge, although much effort has been made to study PD-1/PD-L1 status in pre-treatment tumor. However, tumor infiltrating lymphocyte (TIL) content might also be predictive of response, and our goal was to characterize TIL content and PD-L1 expression in RCC tumors from various anatomic sites. Utilizing a quantitative immunofluorescence technique, TIL subsets were examined in matched primary and metastatic specimens. In metastatic specimens, we found an association between low CD8+ to Foxp3+ T-cell ratios and high levels of PD-L1. High PD-L1-expressing metastases were also found to be associated with tumors that were high in both CD4+ and Foxp3+ T-cell content. Taken together these results provide the basis for combining agents that target the PD-1/PD-L1 pathway with agonist of immune activation, particularly in treating RCC metastases with unfavorable tumor characteristics and microenvironment. In addition, CD8+ TIL density and CD8:Foxp3 T-cell ratio were higher in primary than metastatic specimens, supporting the need to assess distant sites for predictive biomarkers when treating disseminated disease. |
format | Online Article Text |
id | pubmed-4694809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-46948092016-01-20 Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens Baine, Marina K. Turcu, Gabriela Zito, Christopher R. Adeniran, Adebowale J. Camp, Robert L. Chen, Lieping Kluger, Harriet M. Jilaveanu, Lucia B. Oncotarget Research Paper Renal cell carcinoma (RCC) is one of the most chemo- and radio-resistant malignancies, with poor associated patient survival if the disease metastasizes. With recent advances in immunotherapy, particularly with PD-1/PD-L1 blockade, outcomes are improving, but a substantial subset of patients does not respond to the new agents. Identifying such patients and improving the therapeutic ratio has been a challenge, although much effort has been made to study PD-1/PD-L1 status in pre-treatment tumor. However, tumor infiltrating lymphocyte (TIL) content might also be predictive of response, and our goal was to characterize TIL content and PD-L1 expression in RCC tumors from various anatomic sites. Utilizing a quantitative immunofluorescence technique, TIL subsets were examined in matched primary and metastatic specimens. In metastatic specimens, we found an association between low CD8+ to Foxp3+ T-cell ratios and high levels of PD-L1. High PD-L1-expressing metastases were also found to be associated with tumors that were high in both CD4+ and Foxp3+ T-cell content. Taken together these results provide the basis for combining agents that target the PD-1/PD-L1 pathway with agonist of immune activation, particularly in treating RCC metastases with unfavorable tumor characteristics and microenvironment. In addition, CD8+ TIL density and CD8:Foxp3 T-cell ratio were higher in primary than metastatic specimens, supporting the need to assess distant sites for predictive biomarkers when treating disseminated disease. Impact Journals LLC 2015-07-10 /pmc/articles/PMC4694809/ /pubmed/26317902 Text en Copyright: © 2015 Baine et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Baine, Marina K. Turcu, Gabriela Zito, Christopher R. Adeniran, Adebowale J. Camp, Robert L. Chen, Lieping Kluger, Harriet M. Jilaveanu, Lucia B. Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title | Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title_full | Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title_fullStr | Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title_full_unstemmed | Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title_short | Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
title_sort | characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694809/ https://www.ncbi.nlm.nih.gov/pubmed/26317902 |
work_keys_str_mv | AT bainemarinak characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT turcugabriela characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT zitochristopherr characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT adeniranadebowalej characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT camprobertl characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT chenlieping characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT klugerharrietm characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens AT jilaveanuluciab characterizationoftumorinfiltratinglymphocytesinpairedprimaryandmetastaticrenalcellcarcinomaspecimens |